Abstract
The evolution of the recurrence of Crohn's disease after ileal resection and ileocolonic anastomosis closely mimics the natural history of the disease. The pattern of disease does not change after resection compared with that before surgery. New lesions develop within weeks to months after resection in the neoterminal ileum and the severity of these early lesions determine when symptoms and complications recur. This model of early recurrence of Crohn's disease lesions is rather new and drug prevention studies are scarce. A 3-month course of metronidazole (20 m/kg) has been shown to decrease the rate of severe recurrence. Data on 5-aminosalicylic acid therapy are controversial. Claversal seems to be ineffective in preventing recurrence, whereas Pentasa 3 g/day and Asacol 2.4 g/day decreased the rate of endoscopic recurrence, with less symptomatic recurrence observed with the latter drug
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: European Journal of Gastroenterology & Hepatology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
